An increase in large granular lymphocytes (LGL) is frequently seen in patients following allogeneic hematopoietic cell transplantation (allo-HCT) and it has been associated with better outcomes in some reports. We assessed 826 consecutive patients at our institution with over 12Â years of follow-up for the occurrence of LGL lymphocytosis after allo-HCT. The 3-year cumulative incidence of LGL lymphocytosis was 14.5% with a median duration of over 3.5Â years. The development of LGL lymphocytosis was strongly correlated with CMV viremia and GVHD. The clinical course of patients with LGL lymphocytosis after allo-HCT was indolent, with the majority of these patients not displaying any clinical signs or symptoms related to the LGL proliferation. LGL lymphocytosis was associated with better outcomes, including higher overall survival (OS 86.6% vs 44.7% at 3Â years), lower non-relapse mortality (NRM 5.5% vs 30.4% at 3Â years), and lower risk of relapse (8.9% vs 22.9% at 3Â years). A time-dependent multivariable analysis confirmed the favorable impact of LGL lymphocytosis on OS and NRM, but not on the risk of relapse. In multivariable analysis, a longer duration of LGL lymphocytosis was associated with better OS and NRM. Improved immunomodulatory properties of these cells, regulating GVHD and infections, may explain the observed favorable outcomes of patients who developed LGL lymphocytosis following allo-HCT.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/ejh.12899 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Characteristics of large granular lymphocyte leukemia associated with variable common immunodeficiency disorders: A study of 12 cases.
Eur J Haematol
October 2024
Internal Medicine and Infectious diseases, Hôpital Haut-Lévêque, Pessac, France.
Objectives: Common Variable Immunodeficiency Disorders (CVID) and Large Granular Lymphocytes leukemia (LGLL) exhibit diverse clinical manifestations including infections, dysimmunity, and lymphoproliferation. Recent decades have seen the discovery of new genes in the lymphopoiesis pathway, such as JAK-STAT. This case series supplemented by a literature review aims to describe clinical and biological characteristics of patients with both CIVD and LGLL.
View Article and Find Full Text PDFFelty's syndrome.
Front Med (Lausanne)
October 2023
Karl Landsteiner University of Health Sciences, Krems, Austria.
Article Synopsis
- Felty's syndrome, described in 1924, is characterized by a combination of rheumatoid arthritis, splenomegaly, and leucopenia, presenting ongoing diagnostic and treatment challenges nearly a century later.
- The syndrome poses significant risks due to neutropenia, leading to life-threatening infections, with various suggested mechanisms like anti-neutrophil antibodies and neutrophil consumption complicating understanding.
- Current treatment options mainly include methotrexate and rituximab, but evidence for alternatives is limited, highlighting a need for further research and updated treatment approaches.
Clonal cytopenia of undetermined significance (CCUS)-associated reversion of donor-derived, transient αβ T-cell large granular clonal lymphocytosis, emerging post-transplant in a patient with a history of γδ T-cell large granular lymphocytic leukemia.
Cold Spring Harb Mol Case Stud
April 2023
Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, New York 14642, USA;
Article Synopsis
- Autologous and allogeneic hematopoietic stem cell transplantation (HSCT) has changed the treatment landscape for blood cancers, yet challenges remain in predicting related complications.* -
- A case study illustrates donor-derived T-cell clonal lymphocytosis and cytopenia in a patient with a history of T-cell leukemia, revealing clonal unrelatedness through advanced genetic analyses.* -
- Despite the patient experiencing increased mutation loads, their clonal lymphocytosis and anemia resolved, suggesting that genetic changes can influence the blood environment and restore balance, highlighting the importance of comprehensive testing for understanding post-HSCT changes.*
Expansion of large granular lymphocytes after autologous hematopoietic stem cell transplantation.
Int J Hematol
June 2023
Department of Hematology and Oncology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.
Expansion of large granular lymphocytes (LGLs) is sometimes observed in allogeneic hematopoietic stem cell transplantation (HSCT) recipients, and is reported to be associated with a favorable transplant outcome. LGLs are also observed after autologous HSCT, but their clinical implications have not been well investigated. We retrospectively reviewed peripheral blood smears of consecutive autologous HSCT recipients.
View Article and Find Full Text PDFRetrospective Study of T Cell Leukaemia (Large Granular Lymphocyte Variant) in Dogs Associated with Suspected Immune-Mediated Cytopaenia(s) in the Absence of Peripheral Lymphocytosis.
Animals (Basel)
January 2023
Department of Oncology, Dick White Referrals, Station Farm, London Road, Six Mile Bottom CB8 0UH, UK.
Canine chronic large granular lymphocyte (LGL) leukaemia is commonly characterised by moderate to marked lymphocytosis but not neutropaenia. In humans, LGL leukaemia is often associated with autoimmune disorders, including immune-mediated cytopaenias (mainly neutropaenia). This presentation is rare in dogs.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!